All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

20

Reset

20 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • 4D-1503E10 vg, eyePhase 35 trials

    4D Molecular Therapeutics · Neovascular Age-Related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration

  • TiespectusEYE201, MK-8748Phase 35 trials

    EyeBiotech Ltd. · Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization

  • EYP-1901Phase 34 trials

    EyePoint Pharmaceuticals, Inc. · Diabetic Macular Edema, DME, Diabetic Macular Edema (DME)

  • OLN324Phase 34 trials

    Ollin Biosciences, Inc. · Diabetic Macular Edema (DME), Wet Age Related Macular Degeneration, Wet Age-related Macular Degeneration

  • RemigromigEYE103, RestoretPhase 33 trials

    EyeBiotech Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO)

  • BAT5906Phase 32 trials

    Bio-Thera Solutions · Diabetic Macular Edema (DME), Neovascular (Wet) Age-related Macular Degeneration

  • OCS-01Phase 32 trials

    Oculis · Diabetic Macular Edema

  • Tabirafusp tedromerKSI-501Phase 32 trials

    Kodiak Sciences Inc · Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration

  • AVT29proposed aflibercept HD biosimilarPhase 31 trial

    Alvotech Swiss AG · Diabetic Macular Edema

  • Roche (Genentech) · Diabetic Macular Edema

  • RC28-EPhase 31 trial

    RemeGen Co., Ltd. · Diabetic Macular Edema (DME), wAMD

  • BGE-102Phase 22 trials

    BioAge Labs, Inc. · Diabetic Macular Edema (DME), Obesity and Cardiovascular Risk

  • KHK4951Phase 22 trials

    Kyowa Kirin Co., Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD)

  • BI 3812465Phase 21 trial

    Boehringer Ingelheim · Diabetic Macular Edema

  • CU06-1004Phase 21 trial

    Curacle Co., Ltd. · DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)

  • ENN0403Phase 21 trial

    EnnovaBio · Diabetic Macular Edema (DME)

  • INV-102Phase 21 trial

    Invirsa, Inc. · Non-center Involved Diabetic Macular Edema, Non-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy, Diabetic Retinopathy

  • OXU-001DEXAspheresPhase 21 trial

    Oxular Limited · Diabetic Macular Edema

  • RO7446603Phase 21 trial

    Roche (Genentech) · Diabetic Macular Edema

  • SNP318Phase 21 trial

    SciNeuro · Diabetic Macular Edema, DME

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.